| Impact of smoking, smoking cessation, and genetic polymorphisms on CYP1A2 activity and inducibility M Dobrinas, J Cornuz, B Oneda, M Kohler Serra, M Puhl, CB Eap Clinical Pharmacology & Therapeutics 90 (1), 117-125, 2011 | 131 | 2011 |
| Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension I Guessous, M Dobrinas, Z Kutalik, M Pruijm, G Ehret, M Maillard, ... Human molecular genetics 21 (14), 3283-3292, 2012 | 75 | 2012 |
| Simultaneous determination of antidementia drugs in human plasma: Procedure transfer from HPLC–MS to UPLC–MS/MS M Noetzli, N Ansermot, M Dobrinas, CB Eap Journal of pharmaceutical and biomedical analysis 64, 16-25, 2012 | 58 | 2012 |
| Influence of CRTC1 polymorphisms on body mass index and fat mass in psychiatric patients and the general adult population E Choong, L Quteineh, JR Cardinaux, M Gholam-Rezaee, ... JAMA psychiatry 70 (10), 1011-1019, 2013 | 57 | 2013 |
| Quantification of nicotine, cotinine, trans-3′-hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC–tandem mass-spectrometry procedure for a … M Dobrinas, E Choong, M Noetzli, J Cornuz, N Ansermot, CB Eap Journal of Chromatography B 879 (30), 3574-3582, 2011 | 52 | 2011 |
| Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a: CYP2B6: gene resequencing study M Dobrinas, S Crettol, B Oneda, R Lahyani, M Rotger, E Choong, ... Pharmacogenetics and genomics 23 (2), 84-93, 2013 | 51 | 2013 |
| Influence of cytochrome P450 oxidoreductase genetic polymorphisms on CYP1A2 activity and inducibility by smoking M Dobrinas, J Cornuz, L Pedrido, CB Eap Pharmacogenetics and genomics 22 (2), 143-151, 2012 | 43 | 2012 |
| The permeability P-glycoprotein: a focus on enantioselectivity and brain distribution E Choong, M Dobrinas, PA Carrupt, CB Eap Expert opinion on drug metabolism & toxicology 6 (8), 953-965, 2010 | 42 | 2010 |
| Transition of care: A set of pharmaceutical interventions improves hospital discharge prescriptions from an internal medicine ward M Neeman, M Dobrinas, S Maurer, D Tagan, A Sautebin, AL Blanc, ... European journal of internal medicine 38, 30-37, 2017 | 30 | 2017 |
| Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers M Dobrinas, J Cornuz, CB Eap Pharmacogenetics and genomics 23 (5), 286-292, 2013 | 28 | 2013 |
| Clinical pharmacist’s role in implementing a smoking cessation intervention in a Swiss regional hospital: an exploratory study M Dobrinas, AL Blanc, F Rouiller, G Christen, M Coronado, D Tagan, ... International journal of clinical pharmacy 36, 526-534, 2014 | 21 | 2014 |
| Chemical contamination during the preparation of cytotoxics: validation protocol for operators in hospital pharmacies F Sadeghipour, KI Lorenzini, C Ziewitz, M Dobrinas, M Fleury, P Bonnabry Journal of Oncology Pharmacy Practice 19 (1), 57-64, 2013 | 14 | 2013 |
| Prescription of sedative drugs during hospital stay: a Swiss prospective study L Schumacher, M Dobrinas, D Tagan, A Sautebin, AL Blanc, N Widmer Drugs-real world outcomes 4, 225-234, 2017 | 13 | 2017 |
| Cytochrome P4503A pharmacogenetics M Dobrinas, CB Eap HIV PGX 2 (2), 1-3, 2007 | 12 | 2007 |
| Association of nicotine metabolism and sex with relapse following varenicline and nicotine replacement therapy. A Glatard, M Dobrinas, M Gholamrezaee, R Lubomirov, J Cornuz, ... Experimental and clinical psychopharmacology 25 (5), 353, 2017 | 11 | 2017 |
| Lack of Association Between Genetic Polymorphisms of ARRB2 and Alcohol Dependence in a Caucasian Population B Oneda, M Preisig, M Dobrinas, CB Eap Alcohol and alcoholism 45 (6), 590-591, 2010 | 5 | 2010 |
| Influence of body weight and UGT2B7 polymorphism on varenicline exposure in a cohort of smokers from the general population A Glatard, M Guidi, M Dobrinas, J Cornuz, C Csajka, CB Eap European journal of clinical pharmacology 75, 939-949, 2019 | 4 | 2019 |
| Genetic aspects of smoking and impact on clinical care M Dobrinas, J Cornuz, M Puhl, CB Eap Revue Medicale Suisse 5 (210), 1463-1467, 2009 | 3 | 2009 |
| Using risk analysis to anticipate and mitigate failures during a hospital pharmacy relocation L Schumacher, M Dobrinas, S Krähenbühl, C Pasteur, ML Borlat, ... European Journal of Hospital Pharmacy 28 (e1), e164-e170, 2021 | 2 | 2021 |
| Off-label antibiotic preparation M Dobrinas, S Fleury-Souverain, P Bonnabry, F Sadeghipour Ophthalmology 114 (11), 2095-2095. e1, 2007 | 2 | 2007 |
